Liver Disease, Coagulation Testing, and Hemostasis

Clinics in Laboratory Medicine

Volumn 29, Issue 2, 2009, Pages 265-282

  Ng, Valerie L ^a  

^a HIGHLAND HOSPITAL   (United States)

Author keywords

Fresh frozen plasma; International normalized ratio; Liver disease; Prothrombin time; Transfusion

Indexed keywords

FRESH FROZEN PLASMA;

BLEEDING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER DISEASE; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; REVIEW;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; HEMOSTASIS; HUMANS; LIVER DISEASES;

EID: 68149124443     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.05.001     Document Type: Review

References (63)

1. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis 16 1-2 (2003) 17-20
2. Furie B., and Furie B.C. Thrombus formation in vivo. J Clin Invest 115 12 (2005) 3355-3362
3. Kujovich J.L. Hemostatic defects in end stage liver disease. Crit Care Clin 21 3 (2005) 563-587
4. Trotter J.F. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis 10 3 (2006) 665-678 x-xi
5. Mannucci P.M. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. J Thromb Haemost 4 4 (2006) 721-723
6. Thachil J. Relevance of clotting tests in liver disease. Postgrad Med J 84 990 (2008) 177-181
7. Tripodi A. Hemostasis abnormalities in liver cirrhosis: myth or reality?. Pol Arch Med Wewn 118 7-8 (2008) 445-448
8. Senzolo M., Burra P., Cholongitas E., et al. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 12 48 (2006) 7725-7736
9. Hambleton J., Leung L.L., and Levi M. Coagulation: consultative hemostasis. Hematology Am Soc Hematol Educ Program (2002) 335-352
10. Donaldson G.W., Davies S.H., Darg A., et al. Coagulation factors in chronic liver disease. J Clin Pathol 22 2 (1969) 199-204
11. Spector I., and Corn M. Laboratory tests of hemostasis. The relation to hemorrhage in liver disease. Arch Intern Med 119 6 (1967) 577-582
12. Viele M., Atwater S.P., Pham D.T., et al. Revisiting fresh frozen plasma transfusion guidelines: correlation of prothrombin time with individual coagulation factor levels is reagent dependent. Blood 86 Suppl (1995) 355a
13. Medical and Scientific Advisory Committee, National Hemophilia Foundation, NHF. MASAC Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding, 2006). Available at http://www.hemophilia.org/NHFWeb/Resource/StaticPages/menu0/menu5/menu57/170.pdf. Accessed June 18, 2009.
14. Roberts H.R., and Escobar M.A. Chapter 118. Other clotting factor deficiencies. In: Hoffman R., Benz Jr. E.J., Shattil S.J., et al. (Eds). Hematology. Basic principles and practice. 4th edition (2005), Elseviers Churchill Livingston, Philadelphia 2081-2095
15. Zhang B., Spreafico M., Zheng C., et al. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. Blood 111 12 (2008) 5592-5600
16. Zhang B., and Ginsburg D. Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. J Thromb Haemost 2 9 (2004) 1564-1572
17. Peyvandi F., Tuddenham E.G., Akhtari A.M., et al. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol 100 4 (1998) 773-776
18. Pauli R.M., Lian J.B., Mosher D.F., et al. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 41 4 (1987) 566-583
19. Johnson C.A., Chung K.S., McGrath K.M., et al. Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X. Br J Haematol 44 3 (1980) 461-469
20. Goldsmith Jr. G.H., Pence R.E., Ratnoff O.D., et al. Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors. J Clin Invest 69 6 (1982) 1253-1260
21. Brenner B., Tavori S., Zivelin A., et al. Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol 75 4 (1990) 537-542
22. McMahon M.J., and James A.H. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 97 5 Pt 2 (2001) 808-809
23. Chung K.S., Bezeaud A., Goldsmith J.C., et al. Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood 53 4 (1979) 776-787
24. Kaplan M.M., Elta G.H., Furie B., et al. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology 95 3 (1988) 787-792
25. Munoz S.J., Heubi J.E., Balistreri W.F., et al. Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins. Hepatology 9 4 (1989) 525-531
26. Phillips J.R., Angulo P., Petterson T., et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 96 9 (2001) 2745-2750
27. Kowdley K.V., Emond M.J., Sadowski J.A., et al. Plasma vitamin K1 level is decreased in primary biliary cirrhosis. Am J Gastroenterol 92 11 (1997) 2059-2061
28. McPherson R. Specific proteins. In: McPherson R., and Pincus M. (Eds). Henry's clincial diagnosis and management by laboratory methods. 21st edition: Chapter 19 (2007), Saunders Elsevier, Philadelphia 231-244
29. Kelly D.A., O'Brien F.J., Hutton R.A., et al. The effect of liver disease on factors V, VIII and protein C. Br J Haematol 61 3 (1985) 541-548
30. Langley P.G., Hughes R.D., and Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost 54 3 (1985) 693-696
31. Maisonneuve P., and Sultan Y. Modification of factor VIII complex properties in patients with liver disease. J Clin Pathol 30 3 (1977) 221-227
32. Schwarz H.P., Lenting P.J., Binder B., et al. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. Blood 95 5 (2000) 1703-1708
33. Hollestelle M.J., Geertzen H.G., Straatsburg I.H., et al. Factor VIII expression in liver disease. Thromb Haemost 91 2 (2004) 267-275
34. Ten Boekel E., and Bartels P. Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII: C. Pathophysiol Haemost Thromb 32 3 (2002) 137-142
35. Bick R.L. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am 17 1 (2003) 149-176
36. Ferro D., Celestini A., and Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 13 (2009) 21-31
37. Joist J.H. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol 94 10 (1999) 2801-2803
38. Lechner K., Niessner H., and Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Hemost 4 1 (1977) 40-56
39. Francis J.L., and Armstrong D.J. Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease. Haemostasis 11 4 (1982) 215-222
40. Mannucci P.M., and Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 2 8296 (1982) 463-467
41. Northup P.G., Sundaram V., Fallon M.B., et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost 6 1 (2008) 2-9
42. Yamaguchi M., Gabazza E.C., Taguchi O., et al. Decreased protein C activation in patients with fulminant hepatic failure. Scand J Gastroenterol 41 3 (2006) 331-337
43. Bashour F.N., Teran J.C., and Mullen K.D. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95 10 (2000) 2936-2939
44. Escolar G., Cases A., Vinas M., et al. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica 84 7 (1999) 614-619
45. Witters P., Freson K., Verslype C., et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27 11 (2008) 1017-1029
46. Deitcher S.R. Interpretation of the international normalised ratio in patients with liver disease. Lancet 359 9300 (2002) 47-48
47. Fresh frozen plasma: indications and risks. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement 5 5 (1984) 4
48. Contreras M., Ala F.A., Greaves M., et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 2 1 (1992) 57-63
49. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84 3 (1996) 732-747
50. Segal J.B., and Dzik W.H. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45 9 (2005) 1413-1425
51. Kleinman S., Chan P., and Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17 2 (2003) 120-162
52. Stanworth S.J., Brunskill S.J., Hyde C.J., et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126 1 (2004) 139-152
53. Iorio A., Basileo M., Marchesini E., et al. The good use of plasma. A critical analysis of five international guidelines. Blood Transfus 6 1 (2008) 18-24
54. McVay P.A., and Toy P.T. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94 6 (1990) 747-753
55. McVay P.A., and Toy P.T. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 31 2 (1991) 164-171
56. Leslie S.D., and Toy P.T. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 96 6 (1991) 770-773
57. Holland L.L., and Brooks J.P. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126 1 (2006) 133-139
58. Abdel-Wahab O.I., Healy B., and Dzik W.H. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46 8 (2006) 1279-1285
59. Finkbiner R.B., Mc G.J., Goldstein R., et al. Coagulation defects in liver disease and response to transfusion during surgery. Am J Med 26 2 (1959) 199-213
60. Spector I., Corn M., and Ticktin H.E. Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease. N Engl J Med 275 19 (1966) 1032-1037
61. Youssef W.I., Salazar F., Dasarathy S., et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98 6 (2003) 1391-1394
62. Grant A., and Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 45 Suppl 4 (1999) IV1-IV11
63. Gilmore I.T., Burroughs A., Murray-Lyon I.M., et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36 3 (1995) 437-441